Conference Call Scheduled for 12:00 p.m. Eastern Time WEST PALM BEACH, Fla., May 01, 2025 (GLOBE NEWSWIRE) -- AMG (NYSE: AMG) will report financial and operating results for the first quarter ended March 31, 2025 before the market opens on Thursday, May 8, 2025. A conference call will be held at 12:00 p.m. Eastern time on the same day. In addition to quarterly results, the conference call may include discussion of management’s expectations of future financial and operating results. Jay C. Horgen, President ...

THE WOODLANDS, Texas, May 01, 2025 (GLOBE NEWSWIRE) -- TWFG, Inc. (“TWFG”, the “Company”), a high-growth insurance distribution company, announced today the acquisition of two agencies, one in Texas and one in North Carolina, and the hiring of Denise Davis as Vice President of Retail Operations. Denise Davis Insurance, located in Tomball, Texas, converted to a TWFG Corporate Branch on April 1, 2025, after nearly 23 years as an independent TWFG Branch. This move allows Denise to take on the role of Vice Pres ...

(Dollar amounts are in thousands, in Canadian currency unless otherwise specified) GUELPH, Ontario, May 01, 2025 (GLOBE NEWSWIRE) -- Hammond Power Solutions Inc. (“HPS”) (TSX: HPS.A) a leading manufacturer of dry-type transformers, power quality products and related magnetics, today announced its financial results for the first quarter 2025. HIGHLIGHTS Sales of $201 million in the quarter, a 5.6% increase versus Quarter 1, 2024.Adjusted EBITDA of $30,916 in the quarter, or 15.4% of sales. Gross margin was ...

AUSTIN, Texas, May 01, 2025 (GLOBE NEWSWIRE) -- EZCORP, Inc. (NASDAQ: EZPW) (the “Company”), a leading provider of pawn transactions in the United States and Latin America, announced today the retirement of its $103.4 million aggregate principal amount outstanding of 2.375% Convertible Senior Notes Due 2025 (the “2025 Notes”). The 2025 Notes were issued in 2018 with a maturity date of May 1, 2025. In connection with the Company’s election of physical settlement made in October 2024, holders had the right to ...

CALGARY, Alberta, May 01, 2025 (GLOBE NEWSWIRE) -- Petrus Resources Ltd. (“Petrus” or the “Company”) (TSX: PRQ) is pleased to confirm that its Board of Directors has declared a monthly dividend in the amount of $0.01 per share payable May 30, 2025, to shareholders of record on May 15, 2025. The dividend is designated as an eligible dividend for Canadian income tax purposes. Dividend Reinvestment Plan ("DRIP")Petrus' DRIP enables eligible shareholders to reinvest all or part of their cash dividends into addi ...

Core Points - Emergent BioSolutions Inc. has entered a three-year agreement valued at approximately $65 million to supply NARCAN Nasal Spray to the Ontario Ministry of Health for the Ontario Naloxone Program [1] - The agreement aims to enhance access to NARCAN Nasal Spray, which is critical for reversing opioid overdoses, especially given the ongoing opioid crisis in Ontario [2][3] Company Overview - Emergent BioSolutions has been supplying NARCAN Nasal Spray to Ontario since 2018, demonstrating a long-term commitment to addressing opioid poisoning deaths in Canada [1][3] - The company emphasizes the importance of making life-saving medications available to individuals at risk of opioid overdose and their communities [3][4] Industry Context - From January to March 2025, Ontario reported 653 suspected drug-related fatalities, averaging 7 deaths per day, although there was a 30% decrease in overdose deaths compared to the same period in the previous year [2] - The Ontario Naloxone Program is crucial for providing access to naloxone, a life-saving medication, to those at risk of opioid overdose [4]

Financial Performance - Fairfax India Holdings Corporation reported a net loss of $211.2 million ($1.57 net loss per diluted share) in Q1 2025, an improvement from a net loss of $293.5 million ($2.17 net loss per diluted share) in Q1 2024 [1][8] - The company's book value per share decreased by 7.4% to $19.41 as of March 31, 2025, down from $20.96 at December 31, 2024, primarily due to unrealized losses on publicly listed investments [1][7] Investment and Financial Health - As of March 31, 2025, Fairfax India had cash and marketable securities totaling $113.0 million, with an additional $79.2 million available under its revolving credit facility [3] - The company recorded a net change in unrealized losses on investments amounting to $222.9 million, mainly from declines in the fair values of publicly listed investments [6] Shareholder Information - The weighted average number of common shares outstanding during Q1 2025 was 134.8 million, compared to 135.4 million in Q1 2024 [3][9] - The total equity of the company as of March 31, 2025, was $2.747 billion, down from $2.957 billion at the end of 2024 [7]

Core Insights - Coherus BioSciences, Inc. will be webcasting its participation in several upcoming conferences, providing access to presentations via its Investor Events section on the company website [1][2] - The company is a fully integrated commercial-stage innovative oncology firm with an approved PD-1 inhibitor, LOQTORZI®, and a promising pipeline of mid-stage clinical candidates targeting various cancers [4] - Coherus' immuno-oncology pipeline includes multiple antibody immunotherapy candidates aimed at enhancing immune responses against tumors, with ongoing studies for novel treatments [5] Company Overview - Coherus is focused on growing sales of LOQTORZI in nasopharyngeal carcinoma and advancing new indications in combination with pipeline candidates and partners [4] - The company has a robust immuno-oncology pipeline, including Casdozokitug, an IL-27 antagonistic antibody, and CHS-114, a selective anti-CCR8 antibody, both in various stages of clinical trials [5] Upcoming Events - Coherus will participate in the Citizens Life Science Conference on May 8, 2025, at 9:00 a.m. EDT [6] - The company will also present at the HCW BioConnect @ Nasdaq NYC 2025 on May 20, 2025, at 12:00 p.m. EDT [6] - Additional participation includes the TD Cowen 6th Annual Oncology Innovation Summit on May 27, 2025, and the Jefferies Global Healthcare Conference on June 4, 2025 [6]

Core Insights - Fairfax Financial Holdings Limited reported net earnings of $945.7 million in Q1 2025, an increase from $776.5 million in Q1 2024, driven by higher net gains on investments despite a decrease in adjusted operating income to $685.5 million from $977.1 million [1][2][12] - The book value per basic share rose to $1,080.38 as of March 31, 2025, reflecting a 3.5% increase from $1,059.60 at the end of 2024, adjusted for dividends [1][18] Financial Performance - The property and casualty insurance and reinsurance operations generated adjusted operating income of $685.5 million, with a consolidated combined ratio of 98.5% and an underwriting profit of $96.9 million despite catastrophe losses of $781.3 million from California wildfires [2][8][12] - Gross premiums written increased by 5.0% to $8,474.0 million, while net premiums written grew by 8.4% to $6,843.1 million, indicating strong business growth [5][22] Investment Gains - Net gains on investments totaled $1,056.1 million, primarily from common stocks ($779.5 million) and bonds ($388.4 million), reflecting favorable market conditions [3][10][12] - The fixed income portfolio remains conservatively positioned, with 70% in U.S. treasuries and government bonds, and 20% in high-quality corporate bonds [10] Cash and Liquidity - The company ended the quarter with approximately $2.1 billion in cash and marketable securities, alongside $1.7 billion in investments in associates and consolidated non-insurance companies [4][12] Segment Performance - The insurance service result for property and casualty insurance and reinsurance operations was $609.1 million, down from $1,037.5 million in 2024, primarily due to increased catastrophe losses [7][12] - The company recorded a net favorable prior year reserve development benefit of $219.1 million, compared to $29.9 million in 2024 [12][19] Shareholder Returns - The company paid a dividend of $15.00 per common share in Q1 2025, consistent with the previous year [18][20] - The total debt to total capital ratio, excluding non-insurance companies, increased to 25.3% from 24.8% at the end of 2024, reflecting short-term borrowings and preferred share redemptions [16][35]

Financial Performance - Sales from continuing operations for Q1 2025 were $131.7 million, a slight increase of 0.4% compared to $131.2 million in Q1 2024 [3][7] - Adjusted EBITDA decreased to $2.3 million, representing a margin of 1.7%, down from $4.9 million and a margin of 3.7% in the same period last year [3][9] - The net loss from continuing operations was $4.0 million, compared to a loss of $1.8 million in Q1 2024 [3][10] - Cash flow from operating activities decreased to $6.2 million from $11.7 million in the prior year [3][11] Financial Position - As of March 22, 2025, net debt was reduced to $47.1 million from $47.8 million at the end of 2024 [3][12] - The financial leverage ratio increased to 2.8x from 2.4x [3][4] - Working capital decreased to $45.8 million from $50.3 million at the end of the previous fiscal year, attributed to seasonal effects [11][12] Market Dynamics - The growth in purchasing volume with distribution clients is helping the company gain market share despite a slowdown in the restaurant industry [5] - The renewal of a supply agreement with an institutional client at lower margins than in 2024 is impacting financial performance [8][9] - Wholesale activities sales decreased by 3.8%, primarily due to the slowdown in the restaurant industry [8] Strategic Initiatives - The company announced an agreement to acquire the food distribution assets of Alimplus Inc. and its subsidiary Tout-Prêt Inc. for $51.5 million, pending closing conditions [7] - Management is focusing on sound financial management and aims to improve product and customer mix to mitigate the impact of lower-margin contracts [13]